ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,220Medicare Part D Prescriptions Filled, Including Refills

Rank: 39 out of 2094

$911K Total Retail Price of All Prescriptions

Rank: 123 out of 2094

660 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
78% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 660 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

8% of this provider’s 660 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

4% of this provider’s 13,224 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
OMEPRAZOLE 833 650 1 4
MELOXICAM 705 498 2 49
SIMVASTATIN 658 555 3 1
AMLODIPINE BESYLATE 502 445 4 2
METFORMIN HCL 448 360 5 8
FUROSEMIDE 369 295 6 6
GLYBURIDE-METFORMIN HCL 363 302 R 7 94
DIOVAN HCT 358 297 8 28
ZOLPIDEM TARTRATE 350 229 9 14
LEVOTHYROXINE SODIUM 320 250 10 3
AZITHROMYCIN 283 196 11 27
ALENDRONATE SODIUM 278 248 12 30
CLOTRIMAZOLE-BETAMETHASONE 270 173 13 91
NEXIUM 267 207 14 16
METOPROLOL TARTRATE 266 210 15 10
ENALAPRIL MALEATE 257 173 16 25
METOPROLOL SUCCINATE 245 207 17 9
CRESTOR 239 210 18 15
LISINOPRIL 214 141 19 7
HYDROCHLOROTHIAZIDE 208 161 20 12
DIOVAN 205 172 21 13
LISINOPRIL-HYDROCHLOROTHIAZIDE 201 150 22 55
NAPROXEN 191 125 23 84
ATORVASTATIN CALCIUM 182 176 24 5
JANUMET 181 131 25 86
CLOPIDOGREL 173 154 26 22
LOSARTAN POTASSIUM 167 137 27 17
PROAIR HFA 166 110 28 45
TAMSULOSIN HCL 155 136 29 29
IBUPROFEN 153 103 30 73
CIPROFLOXACIN HCL 147 115 31 81
ADVAIR DISKUS 146 101 32 36
ENDOCET 134 64 S2 33 88
CYCLOBENZAPRINE HCL 133 70 R 34 115
CARVEDILOL 133 122 34 19
DONEPEZIL HCL 129 102 36 20
LOSARTAN-HYDROCHLOROTHIAZIDE 125 109 37 52
AMLODIPINE BESYLATE-BENAZEPRIL 124 108 38 58
GLIMEPIRIDE 122 90 39 31
PLAVIX 121 111 40 38
MECLIZINE HCL 118 111 41 103
TRAMADOL HCL 114 70 42 33
JANUVIA 113 111 43 35
ACTOS 112 100 44 112
GLYBURIDE 106 80 R 45 95
NIFEDIPINE ER 106 80 45 96
ACETAMINOPHEN-CODEINE 104 96 S3 47 129
BETAMETHASONE DIPROPIONATE 97 71 48 202
LYRICA 89 57 49 85
GLIPIZIDE ER 87 75 50 126
SINGULAIR 86 47 51 64
VOLTAREN 84 73 52 109
LANSOPRAZOLE 83 69 53 144
LEVOFLOXACIN 83 61 53 70
GABAPENTIN 77 45 55 23
CLONIDINE HCL 76 71 56 62
WARFARIN SODIUM 75 73 57 11
RANITIDINE HCL 72 50 58 80
FAMOTIDINE 70 63 59 34
METFORMIN HCL ER 66 54 60 67
EXFORGE 66 56 60 105
POTASSIUM CHLORIDE 65 64 62 24
SERTRALINE HCL 62 41 63 26
GLIPIZIDE 61 48 64 82
ACTOPLUS MET 61 51 64 406
GLIPIZIDE XL 61 43 64 122
RAMIPRIL 60 60 67 48
VERAPAMIL ER 59 48 68 161
OXYCODONE-ACETAMINOPHEN 58 28 S2 69 40
ATENOLOL 57 57 70 21
BENICAR 57 52 70 108
PRAVASTATIN SODIUM 56 41 72 18
LIPITOR 54 40 73 39
LOVAZA 53 27 74 53
AMOX TR-POTASSIUM CLAVULANATE 52 41 75 107
FLUTICASONE PROPIONATE 52 23 75 41
ATENOLOL-CHLORTHALIDONE 51 42 77 220
AZOR 50 45 78 155
PROCTOZONE-HC 50 38 78 266
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.